Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Subthreshold psychiatric disorders do not fully meet the diagnostic criteria of syndromal disorders but may be associated with comparable disability. To investigate the anxiolytic effect of Silexan, an active substance from lavender oil for oral administration, in patients with subthreshold anxiety, a meta-analysis that included all published trials with Silexan in this indication was performed. Three randomised, placebo-controlled trials in subthreshold anxiety disorders (anxiety disorder not otherwise specified, restlessness and agitation, mixed anxiety and depressive disorder) were included. Eligible participants with a baseline Hamilton Anxiety Rating Scale (HAMA) total score ≥ 18 points received 1 × 80 mg/day Silexan or placebo for 10 weeks. Outcomes included the HAMA, the Pittsburgh Sleep Quality Index, the Zung Self-rating Anxiety Scale, the Clinical Global Impressions questionnaire and the SF-36 health status inventory. Data were analysed using meta-analysis based on pooled raw data of individual patients (random effects models). A total of 697 patients were assessed for efficacy. Silexan was superior to placebo in reducing the HAMA total score during 10 weeks' treatment [mean value difference, 95% confidence interval: 3.83 (1.28; 6.37) points]. Superiority was comparably pronounced for psychic and somatic anxiety as well as for observer- and self-rated anxiety. Silexan had a beneficial effect on sleep (secondary to the anxiolytic effect) without causing sedation and improved the patients' health-related quality of life. Adverse event incidence in both treatment groups was comparable [risk ratio: 1.06 (0.85; 1.33)]. Silexan has a significant and clinically meaningful anxiolytic effect in subthreshold anxiety. The results cannot be generalised to other lavender oil products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of individual participant data: rationale, conduct, and reporting
Riley, R. D., Lambert, P. C., & Abo-Zaid, G. (2010) · BMJ · doi:10.1136/bmj.c221 · Cited by 1,701 · cited 1×
“We used a two-stage individual participant data (IPD) meta-analysis approach according to which the outcomes of interest were first analysed equally within each study and then combined using ‘traditional’ meta-analysis [29, 30].”
MethodMaier, W., Buller, R., Philipp, M., & Heuser, I. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90072-9 · Cited by 1,044 · cited 1×
“Moreover, we analysed the change of the HAMA psychic and somatic anxiety subscores [27] as well as of the individual item scores for anxious mood, tension, and sleep.”
MethodGeneralized anxiety disorder: prevalence, burden, and cost to society
Wittchen, H.-U. (2002) · Depression and Anxiety · doi:10.1002/da.10065 · Cited by 733
SSRI Antidepressant Medications: Adverse Effects and Tolerability
Ferguson, J. M. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0105 · Cited by 669 · cited 1×
“Other common side effects of SSRIs and/or hydroxyzine include anticholinergic reactions, gastrointestinal disturbances, weight gain, sexual dysfunction, or agitation and irritability [41, 42].”
BackgroundBurke, D. L., Ensor, J., & Riley, R. D. (2017) · Statistics in Medicine · doi:10.1002/sim.7141 · Cited by 538 · cited 1×
“We used a two-stage individual participant data (IPD) meta-analysis approach according to which the outcomes of interest were first analysed equally within each study and then combined using ‘traditional’ meta-analysis [29, 30].”
MethodBandelow, B., Sher, L., Bunevicius, R., Hollander, E., Kasper, S., Zohar, J., Möller, H.-J., WFSBP Task Force on Mental Disorders in Primary Care, & WFSBP Task Force on Anxiety Disorders, O. A. P. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2012.667114 · Cited by 428
Self-citationGaps in accessing treatment for anxiety and depression: challenges for the delivery of care
Collins, K. A., Westra, H. A., Dozois, D. J. A., & Burns, D. D. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.06.001 · Cited by 322
The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review
Haller, H., Cramer, H., Lauche, R., Gass, F., & Dobos, G. J. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-128 · Cited by 267
Karsten, J., Hartman, C. A., Smit, J. H., Zitman, F. G., Beekman, A. T. F., Cuijpers, P., van der Does, A. J. W., Ormel, J., Nolen, W. A., & Penninx, B. W. J. H. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.080572 · Cited by 155 · cited 1×
“These findings underline the need for an early and adequate treatment of SSAD, which could also efficiently and cost-effectively prevent a progression to the syndromal level [8, 9].”
BackgroundThe prevalence of anxiety and associated factors in a multiracial sample of older adults
Cohen, C. I., Magai, C., Yaffee, R., & Walcott-Brown, L. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.12.1719 · Cited by 93
Cited by
Strawn, J. R., Geracioti, L., Rajdev, N., Clemenza, K., & Levine, A. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1491966 · Cited by 214
“Additionally, in a meta-analysis of silexan in patients with sub-threshold anxiety (K = 3), a significant effect was observed ‘for observer- and self-rated anxiety’ in addition to sleep and quality of life and this compound was well-tolerated [120].”
MethodMedicinal herbs for the treatment of anxiety: a systematic review and network meta-analysis
Zhang, W., Yan, Y., Wu, Y., Yang, H., Zhu, P., Yan, F., Zhao, R., Tian, P., Wang, T., Fan, Q., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106204 · Cited by 75
Trkulja, V., & Barić, H. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_22 · Cited by 28
Metadata
- Authors
- Möller, H.-J., Volz, H.-P., Dienel, A., Schläfke, S., & Kasper, S.
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2017-11-17
- Volume
- 269
- Issue
- 2
- Pages
- 183-193
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2770656902
- Cited by
- 49
- References
- 14
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.